Add a Thiazide or Thiazide-Like Diuretic to the Current Amlodipine
For this 74-year-old patient with uncontrolled hypertension on amlodipine 5 mg, the best next step is to add a thiazide or thiazide-like diuretic (such as hydrochlorothiazide 12.5-25 mg or chlorthalidone 12.5-25 mg) to the current regimen. This recommendation is based on the most recent 2020 International Society of Hypertension guidelines 1 and aligns with multiple international consensus statements 2.
Rationale for Adding a Thiazide Diuretic
The 2020 ISH guidelines specifically recommend for non-Black patients aged >80 years or frail elderly to follow this stepwise approach 1:
- Step 1: Low-dose ACEI/ARB or increase CCB to full dose
- Step 2: Add thiazide/thiazide-like diuretic
- Step 3: Consider spironolactone if still uncontrolled
Since your patient is already on amlodipine (a CCB), the logical progression is either to:
- Increase amlodipine from 5 mg to 10 mg 3 (maximum approved dose)
- Add a thiazide diuretic to the current dose
The combination of CCB + thiazide diuretic is specifically recommended as a preferred two-drug combination across multiple guidelines 2, 1. This combination has demonstrated superior efficacy in elderly patients and is well-tolerated.
Specific Medication Recommendations
Option 1: Increase Amlodipine + Add Diuretic (Preferred)
- Amlodipine 10 mg once daily (titrate from current 5 mg) 3
- Plus hydrochlorothiazide 12.5-25 mg once daily OR chlorthalidone 12.5-25 mg once daily
The 2024 ESC guidelines emphasize that thiazide-like diuretics (chlorthalidone, indapamide) have demonstrated the most effective reduction in BP and cardiovascular events 4. A 1996 study demonstrated that when amlodipine/lisinopril combination failed, adding a thiazide diuretic (bendrofluazide 5 mg) was significantly more effective than adding a beta-blocker 5.
Option 2: Add ACE Inhibitor or ARB
If diuretics are contraindicated or not tolerated, the alternative is adding an ACE inhibitor (such as lisinopril 10-20 mg) or ARB (such as losartan 50-100 mg) to amlodipine 2, 1. The combination of CCB + ACEI/ARB is also a guideline-recommended preferred combination.
Special Considerations for Rheumatoid Arthritis
The patient's rheumatoid arthritis medication requires specific attention:
ACE inhibitors or ARBs are actually preferred in patients with inflammatory arthritis due to their potential anti-inflammatory properties 6. The 2010 EULAR guidelines specifically state: "Statins, ACE-inhibitors and/or angiotensin II blockers are preferred treatment options due to their potential anti-inflammatory effects" 6.
Recent 2025 research confirms that RA increases hypertension risk through inflammatory mechanisms 7, and a 2026 position paper emphasizes that hypertension management in autoimmune rheumatic diseases should follow general recommendations but with consideration of anti-inflammatory effects 8.
Therefore, if adding a second agent beyond optimizing the diuretic, an ACE inhibitor or ARB would be particularly beneficial in this patient with RA.
Practical Implementation Algorithm
- First: Increase amlodipine to 10 mg once daily (if not already done) 3
- Second: Add hydrochlorothiazide 12.5-25 mg OR chlorthalidone 12.5-25 mg once daily 1, 4
- Monitor: Reassess BP in 2-4 weeks 2
- If still uncontrolled: Add ACE inhibitor (lisinopril 10-20 mg) or ARB (losartan 50-100 mg) to create a three-drug combination (CCB + thiazide + ACEI/ARB) 1
- Target BP: Aim for <140/90 mmHg, individualized based on frailty status 1. The 2024 ESC guidelines recommend targeting 120-129 mmHg systolic if well-tolerated 4, but for a 74-year-old, <140/90 mmHg is appropriate initially.
Important Caveats
Avoid hypokalemia: When using thiazide diuretics, monitor potassium levels as hypokalemia should be avoided 9, 10, 11. Consider potassium supplementation or a potassium-sparing agent if needed.
Single-pill combinations: Once the regimen is established, consider switching to a single-pill combination (such as amlodipine/hydrochlorothiazide or amlodipine/valsartan/hydrochlorothiazide) to improve adherence 1, 4. A 2026 study demonstrated that triple-combination single-pill therapy (olmesartan/amlodipine/hydrochlorothiazide) is well-tolerated and effective in elderly patients, including those ≥80 years 12.
Drug interactions with RA medications: There are no significant contraindications between standard antihypertensives and common RA biologics (such as TNF inhibitors, IL-6 inhibitors, or JAK inhibitors). However, NSAIDs commonly used in RA can reduce the effectiveness of antihypertensives and increase cardiovascular risk 6, so minimize NSAID use when possible.
Frailty assessment: Given the patient's age, assess for frailty. If frail, consider monotherapy initially or slower titration 1.